Mice bearing the Em-myc transgene, which links the immunoglobulin heavy chain enhancer (Em) with c-myc, are predisposed to developing B cell lymphomas. Several B lineage cell lines have been isolated from these animals, and some have been converted to macrophages following infection with v-raf. In this study we compared the regulation of myc expression in Em-myc B lymphoma lines, their macrophage counterparts and other non-myc transformed B cell lines. Nuclear run-on analyses demonstrated that transcription of the transgene was elevated in Em-myc B cell lines. Moreover, the presence of a 600 bp fX174 marker in the 3' end of the transgene produced a marked stabilisation of this RNA species. Consequently, steady state myc mRNA levels in the Emmyc B lymphoma cells were tenfold higher than the macrophage derivatives and non-myc transformed B lineage lines. Despite the considerable dierence in myc RNA levels, the Em-myc B cell lines contained only 30 ± 50% more Myc protein than the other cell lines. This discrepancy between RNA and protein content was not due to increased degradation of the protein as the half life was normal in the transgenic cell lines. These results indicate that both Em and fX174 sequences in¯uence transgenic myc expression and that protein levels do not correlate with RNA content in Em-myc cell lines.
Expression of the myc gene is subject to an elaborate array of transcriptional, post-transcriptional and translational regulatory mechanisms and perturbation of these controls has been implicated in the genesis of a wide range of tumours (Spencer and Groudine, 1991) . Translocations involving immunoglobulin loci and cmyc have been identi®ed in Burkitt's lymphoma and murine plasmacytomas (Cory, 1986) . To investigate the role of the immunoglobulin heavy chain enhancer (Em) in these tumours, Adams et al. (1985) generated transgenic mice coupling this enhancer to c-myc. In addition, a fragment of fX174 was introduced into the 3' untranslated region (3'UTR) of the transgene to generate a larger transcript which could easily be distinguished from the endogenous myc mRNA. Expression of Em-myc was restricted to the B lymphoid compartment and transgenic animals contained abnormally high levels of early B cells before succumbing to B lineage lymphomas Langdon et al., 1986; Langdon et al., 1988) . Transgene RNA levels were ®ve to sixfold greater in Em-myc splenocytes and cell lines than c-myc in the spleens of non-transgenic littermates (Alexander et al., 1987) . It was presumed that`the malignancy is a consequence of high constitutive myc expression within the lymphoid compartment, forced by enhancers which are activated by lymphoid factors' . nuclei were isolated from each cell line and transcription allowed to proceed in the presence of [ 32 P]UTP (Linial et al., 1985) . Labelled transcripts were hybridised to membranes containing probes for myc (Stanton et al., 1983) , Cm (Gough et al., 1980) and GAPDH (Piechaczyk et al., 1984) . Annealed transcripts were detected by phosphorimager (a) and their levels expressed relative to GAPDH (b). Black histograms represent myc:GAPDH, while the white histograms are Cm:GAPDH. The cell lines used were: Em-myc pre-B and B lymphoma cells (1Bra, 2Mes, 3Mes), their vraf infected macrophage derivatives (1Bra/raf, 2Mes/raf, 3Mes/ raf), a plasmacytoma (MPC 11) and a non-myc transformed B lymphoma (WEHI 231) In subsequent studies, Em-myc B lymphoma lines were infected with a retrovirus expressing v-raf, resulting in the conversion of these lymphoid cells into macrophages (Klinken et al., 1988) . One consequence of this lineage switch was a marked reduction in Em-myc transcripts in the myeloid derivatives. However, the mechanism for the decrease in myc RNA was not determined ± it could result from reduced transcription or increased turnover of the transcripts. Interestingly, Em-myc expression was not observed in normal macrophages isolated from transgenic animals (Alexander et al., 1987) .
In this study we compared the regulation of Em-myc expression in transgenic B lymphoma lines with the macrophage derivatives, as well as non-myc transformed B lineage lines. Previous studies had shown elevated steady state RNA levels of myc by Northern blotting and S1 nuclease assays Alexander et al., 1987) , but direct measurement of transcription was not undertaken. Here we have used nuclear run-on assays to determine the impact of Em on myc transcription. In addition, the eect of the fX174 tag on the degradation of transgene RNA was examined, since it has been shown that the 3'UTR in¯uences turnover of myc transcripts and interference with this non-coding region can aect stability of the RNA (Bonnieu et al., 1988; Cole and Mango, 1990; Laird-Oringa, 1992) . Finally, the Myc protein content was assessed and compared with the relative abundance of myc RNA. As most investigations have shown a direct relationship between myc RNA and protein (Hann and Eisenman, 1984; Persson et al., 1985; Rabbitts et al., 1985; Hann et al., 1985) , it was anticipated that a marked increase in Myc protein would be detected in Em-myc B lymphoma cells that matched the raised RNA levels.
Nuclear run-on assays were employed to measure the transcriptional activity of myc in transgenic and non-transgenic lines: Cm transcription was ascertained simultaneously as this immunoglobulin constant region is also in¯uenced by Em (Banerji et al., 1983; Gillies et al., 1983; Grosschedl and Baltimore, 1985) . Data presented in Figure 1 show that each of the Em-myc pre-B and B lymphoma lines viz 1Bra, 2Mes, 3Mes transcribed the transgene to similar degrees i.e. approximately 12 to 19 times that of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) control. Use of a probe encompassing the fX174 marker sequence indicated that virtually all myc transcripts in these cells emanated from the transgene and proceeded unimpeded through to the 3' end of the gene (data not shown). Interestingly, transcription of myc in MPC11, a plasmacytoma line bearing a c-myc/ immunoglobulin translocation (Stanton et al., 1984; Cory, 1986) , was comparable with that of the Em-myc B lymphoma cells. In contrast, transcription of Em-myc 
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Figure 2 Determination of Em-myc and c-myc mRNA half lives by RNase protection assay. The rate of myc RNA turnover was determined by RNase protection assay (Goodall et al., 1990) . (a) Em-myc and c-myc transcripts were detected using a probe derived from a 202 bp HpaI/HindIII fragment of the transgene bearing 74 bp of fX174 at its 5' end and 128 bp of c-myc exon 3 at its 3' terminus . This sequence was subcloned into SmaI/HindIII digested pGEM 3Zf(+) and when linearised with EcoRI provided a template for transcription by SP6 RNA polymerase of a 228 nt antisense RNA probe of which 202 nt were homologous to the transgene and 128 nt to c-myc. GAPDH mRNA was detected with a 164 nt antisense transcript of which 120 nt was speci®c for this gene. Actinomycin D (10 mg/ml) was added to WEHI 231 and 3Mes cultures thereby inhibiting transcription by 495% according to [ 3 H]uridine incorporation into RNA. Samples from these cultures were removed at 20 min intervals between 0 to 60 min post treatment and total RNA prepared from them using the method of Chomczynski and Sacchi (1987) . The decay of myc transcripts in WEHI 231 and 3Mes are depicted in (b) and (c) respectively. The estimated half lives of these mRNAs is presented in (d). Abbreviations: SP6, SP6 RNA polymerase; H, HindIII; Hp, HpaI; S, SmaI; R, EcoRI; X, XhoI; nt, nucleotide; bp, base pair. Em sequence (white box); c-myc exons (black boxes); fX174 (stippled box); Plasmid sequence (oblique line box) was four-to sixfold higher than that of c-myc in the B cell line WEHI 231. In the macrophage lines 1Bra/raf, 2Mes/raf, 3Mes/raf (Klinken et al., 1988) transcription of Em-myc was reduced by 50 to 80% compared with the parental B cell lines. This down regulation was more apparent in the mature macrophage lines 1Bra/ raf and 3Mes/raf. A similar pattern of transcriptional suppression was observed when Cm transcription was compared between the lymphoid and myeloid lines i.e. decreases were observed in the more mature macrophage lines, while little change was detected in the immature macrophage line 2Mes/raf. Together these data indicate that Em may enhance myc transcription in B cells, but is less eective in cells that have undergone lineage conversion to the myeloid pathway. These results support the contention of Adams et al. (1985) that the enhancer forces high constitutive expression of myc in B lymphoid cells.
To examine whether Em-myc mRNA had been stabilised by the fX174 insert, an RNase protection assay was developed to measure the turnover of myc transcripts (Figure 2a) . The half lives of RNA from the transgene and its cellular counterpart were estimated in 3Mes and WEHI 231 cells treated with Actinomycin D. The results were expressed relative to GAPDH, since this RNA species is known to have a half life of greater than 4 h (Linial et al., 1985; Piechaczyk et al., 1985; Laird-Oringa et al., 1990) . Figure 2b and d show that c-myc mRNA decayed rapidly in WEHI 231 cells, with a half life of approximately 25 min. This result is comparable with data obtained by numerous other groups who have estimated the half life of c-myc to be between 15 and 30 min (Piechaczyk et al., 1985; Jones and Cole, 1987; Bonnieu et al., 1988) . In contrast, the transgene mRNA appeared to be far more stable, with an estimated half life of 90 min (Figure 2c and d) . Other transgenic B lymphoma (2Mes) and macrophage (3Mes/raf) lines had similar mRNA turnover rates (data not shown). These data indicate that Em-myc mRNA was approximately three times more stable than c-myc transcripts in comparable B lymphoma cells. As the 3'UTR is crucial for rapid myc mRNA turnover (Bonnieu et al., 1988; Cole and Mango, 1990; Laird-Oringa, 1992) , insertion of the fX174 sequence into this AU rich region has probably led to the increased stability of the transcripts. The reduced degradation rate of Em-myc mRNA must, therefore, contribute to the overall increase in myc transcripts within these cells. Interestingly, a number of mutations to myc have been described which alter the transcript turnover rate (Piechaczyk et al., 1985; Hollis et al., 1988; Bauer et al., 1989; Aghib et al., 1990) .
Having observed increases in Em-myc transcription ( Figure 1 ) and mRNA stabilisation (Figure 2) , steady state RNA levels of myc were compared by RNase protection assay in a panel of Em-myc and nontransgenic cell lines. The results displayed in Figure 3 show that the amount of myc RNA in the three transgenic B lymphoma lines (1Bra, 2Mes and 3Mes) was at least tenfold greater than c-myc in the pre-B line 70Z and the B cell line WEHI 231, but was only double that of the plasmacytoma MPC11. As anticipated the mature Em-myc macrophage lines 1Bra/raf and 3Mes/raf had reduced levels of Em-myc transcripts, although the less dierentiated 2Mes/raf still expressed considerable transgene mRNA. These results are similar to data obtained previously with S1 nuclease assays and Northern blots Alexander et al., 1987; Klinken et al., 1988) . It should be noted that the steady state RNA ratio of myc:GAPDH is less than the relative transcription rates (Figure 1 ) due to the longer half life of GAPDH transcripts. We conclude from these experiments that the elevated levels of myc RNA seen here (Figure 3) , and previously Alexander et al., 1987) , are due not only to increased transcription driven by Em, but also to the fX174-induced stabilisation of the transcript. However, two points are noteworthy. First, the Em-myc construct used as a transgene was originally isolated from a DNA rearrangement in a murine plasmacytoma (Corcoran et al., 1985) . Second, mice in a separate transgenic line combining Em and myc, without a 3'UTR tag, also developed B cell lymphomas (Schmidt et al., 1988 ). These observations demonstrate that although the fX174 tag may contribute to raising transgenic myc RNA levels, the enhancer alone is capable of promoting myc-induced tumours.
Most previous studies have shown that Myc protein levels correlate well with the RNA content of cells (Hann and Eisenman, 1984; Persson et al., 1985; Rabbitts et al., 1985; Hann et al., 1985) . Immunoblotting was used to determine whether the elevated myc mRNA observed in the Em-myc B lymphoma cells Figure 4a show that unlike the considerable dierences in transcript levels (Figure 3) , the Myc protein content of Em-myc B cell lines was only 30 ± 50% greater than that of the v-raf derived macrophages. Furthermore, the Em-myc B lineage lines contained similar Myc protein levels to WEHI 231 ( Figure 4a ) and 70Z cells (data not shown). MPC11 appeared to contain more Myc protein, but quantitation was not possible due to the contaminating immunoglobulin band. These unexpected results were observed on four separate occasions using two dierent antibodies against Myc protein. Therefore, in spite of the large dierence in transcript levels between the Emmyc B lymphoma cells and macrophages, as well as other B cell lines, the variation in protein levels was far less dramatic. To investigate whether changes to Myc protein stability may account for the discrepancy between RNA and protein levels in Em-myc cell lines, the turnover rate of the protein was assessed. Myc protein normally has a half life of between 20 and 30 min (Hann and Eisenman, 1984; Rabbitts et al., 1985; Persson et al., 1985) . However, alterations to this turnover rate have been observed which can aect accumulation of the protein (Wingrove et al., 1988; Spotts and Hann, 1990) . Cultures of 3Mes were treated with cycloheximide and immunoblotting of cell lysates revealed that Myc protein in these cells had a half life of approximately 25 min (Figure 4b and c) . To con®rm that Myc protein was being selectively degraded, the same membrane was probed for p44 MAP kinase and c-raf expression. Figure 4 shows that these proteins were more stable than Myc over the same period. Similar results were observed with other Em-myc B lymphoma lines (data not shown). These results demonstrate that Myc turnover is normal in the Emmyc cell lines and that the discordance between transcript and protein content is not due to reduced protein stability.
The disparity between myc RNA and protein in Emmyc cell lines is strikingly similar to a report by Bauer et al. (1989) . These investigators observed tenfold dierences in c-myc RNA levels between plasmacytoma and B cell lines, but could detect no dierence in protein content. Thus, large increases in myc RNA levels do not necessarily translate into markedly elevated amounts of protein. It has also been shown that myc RNA and protein do not correlate during dierentiation of murine erythroleukaemia cells (Wingrove et al., 1988; Spotts and Hann, 1990) . Although most studies have demonstrated that myc transcripts and protein levels are directly related (Hann and Eisenman, 1984; Persson et al., 1985; Rabbitts et al., 1985; Hann et al., 1985) , the data presented here support previous reports that translational and posttranslational regulatory mechanisms play an important role in ultimately determining Myc protein content of cells (Darveau et al., 1985; Parkin et al., 1988; Lazarus et al., 1988; Spotts and Hann, 1990) . One possible explanation for the unexpectedly low Myc protein content in Em-myc B cell lines involves the ratio of transcripts generated from the two promoters, P 1 and P 2 . Alexander et al. (1987) found that the ratio of P 1 to P 2 initiated transcripts in the Em-myc B cells was 1 : 1, whereas in non-myc transformed lines this ratio is approximately 1 : 10 (Cole, 1986) . Signi®cantly, it has been shown that translation is less ecient for myc transcripts that contain longer 5'UTRs (Darveau et al., 1985; Parkin et al., 1988) . Thus, while there are elevated levels of myc transcripts in the transgenic lines, half contain the extended 5'UTR which may be subject to translational suppression. This could result in the lower than predicted Myc protein levels.
In summary, the regulation of Em-myc expression is complex. Two extrinsic elements, Em and the fX174 marker, clearly in¯uence transcription and RNA turnover to produce a large increase in myc transcripts. However, this accumulation of myc RNA does not result in massive increases in Myc protein.
The marginal rise in Myc protein suggests that intrinsic translational control plays a major role in controlling the amount of protein ®nally produced. Given the slight increase in protein content, it is striking that virtually all Em-myc mice develop lymphomas (Adams et al., 1995) . Assuming that the levels of Myc proteins in the transgenic B lymphoma lines accurately re¯ect the amount in cells in vivo, then a doubling of Myc protein is sucient to promote lymphomagenesis. It appears that large increases in Myc protein may not be as crucial for neoplasia as constitutive expression.
